Literature DB >> 26647865

Psychosocial functioning in relation to symptomatic remission: A longitudinal study of first episode schizophrenia.

K Jaracz1, K Górna2, J Kiejda2, B Grabowska-Fudala2, J Jaracz3, A Suwalska3, J K Rybakowski3.   

Abstract

OBJECTIVES: The aims of the study were: (1) to evaluate longitudinally symptomatic remission in first-episode (FE) schizophrenia, (2) to describe symptoms, social functioning and quality of life (Qol) in relation to remission status, and (3) to determine the long-term outcome of schizophrenia and its early predictors.
METHODS: Sixty-four patients were assessed 1 month after a first hospitalization (T1), 12 months (T2), 4-6 years (T3), and 7-11 years (T4) after T1. The patients were allocated to three remission groups according to their remission status over the whole observation period, e.g. stable remission (SR), unstable remission (UR) and non-remission (NR). The PANSS, Social Functioning Scale and WHOQoL were used to evaluate the patients' psychosocial functioning levels, symptomatic and functional remissions and satisfying QoL. A good outcome was defined as meeting, simultaneously, the criteria of symptomatic and functional remissions and satisfying QoL at T4, while failure to meet all of these criteria was defined as a poor outcome.
RESULTS: Among them, 17.2% patients were in stable remission, 57.8% in unstable remission and 25.0% were unremitted at all time points. The SR group had lower levels of psychopathological symptoms and reported better social functioning and QoL than the NR group. During the follow-up, the symptoms increased, social functioning slightly improved and QoL did not change. At T4, 53% of the sample had a poor outcome, which was independently predicted by the longer duration of untreated psychosis and a lack of satisfying QoL at T1.
CONCLUSIONS: Our results demonstrate that: (1) the long-term course in schizophrenia is heterogeneous and that three illness trajectories exist, (2) social functioning and QoL are only partially connected with symptomatic remission (3), the risk of a poor outcome may potentially be reduced by appropriate interventions at an early stage of the illness.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  First episode; Long-term study; Quality of life; Remission; Schizophrenia; Social functioning

Mesh:

Year:  2015        PMID: 26647865     DOI: 10.1016/j.eurpsy.2015.08.001

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  7 in total

1.  Untreated illness and recovery in clients of an early psychosis intervention program: a 10-year prospective cohort study.

Authors:  Gina Bhullar; Ross M G Norman; Neil Klar; Kelly K Anderson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-11-29       Impact factor: 4.328

2.  Care gap: a comprehensive measure to quantify unmet needs in mental health.

Authors:  S Pathare; A Brazinova; I Levav
Journal:  Epidemiol Psychiatr Sci       Date:  2018-03-09       Impact factor: 6.892

3.  Quality of life in first episode psychosis: a cluster analytic approach.

Authors:  Z Liao; K Allott; J F I Anderson; E Killackey; S M Cotton
Journal:  Qual Life Res       Date:  2021-10-18       Impact factor: 4.147

Review 4.  Schizophrenia outcomes in the 21st century: A systematic review.

Authors:  Peter Huxley; Anne Krayer; Rob Poole; Louise Prendergast; Sanjaya Aryal; Richard Warner
Journal:  Brain Behav       Date:  2021-05-15       Impact factor: 2.708

5.  The 10-year functional outcome of schizophrenia in Butajira, Ethiopia.

Authors:  Derege Kebede; Abebaw Fekadu; Teshome Shibre Kelkile; Girmay Medhin; Charlotte Hanlon; Rosie Mayston; Atalay Alem
Journal:  Heliyon       Date:  2019-03-14

6.  The Association of Social Support and Symptomatic Remission among Community-Dwelling Schizophrenia Patients: A Cross-Sectional Study.

Authors:  Chi-Hsuan Fan; Shih-Chieh Hsu; Fei-Hsiu Hsiao; Chia-Ming Chang; Chia-Yih Liu; Yu-Ming Lai; Yu-Ting Chen
Journal:  Int J Environ Res Public Health       Date:  2021-04-09       Impact factor: 3.390

7.  Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).

Authors:  Joanna Moncrieff; Glyn Lewis; Nick Freemantle; Sonia Johnson; Thomas R E Barnes; Nicola Morant; Vanessa Pinfold; Rachael Hunter; Lyn J Kent; Ruth Smith; Katherine Darton; Robert Horne; Nadia E Crellin; Ruth E Cooper; Stefan Priebe
Journal:  BMJ Open       Date:  2019-11-27       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.